EPO Rules European Nexium® Process Patent Valid
- Details
- Category: AstraZeneca

Aptivus® (tipranavir) capsules granted full approval by the U.S. FDA
- Details
- Category: Boehringer Ingelheim

Aclasta® receives European approval as first once-yearly treatment for postmenopausal osteoporosis
- Details
- Category: Novartis

GSK seeks prequalification for Cervarix⢠from the World Health Organization
- Details
- Category: GlaxoSmithKline

Shire's ELAPRASE® (idursulfase) Approved in Japan For the Treatment of Hunter Syndrome
- Details
- Category: Shire

Pfizer Launches Independent Biotherapeutics and Bioinnovation Center
- Details
- Category: Pfizer

Boehringer Ingelheim comments the nevirapine production for Rwanda by Apotex
- Details
- Category: Boehringer Ingelheim

More Pharma News ...
- GSK applies for licence to market OTC weight loss product In Europe
- Herceptin eradicates tumours and may reduce the need for mastectomies
- Bionas Signs Service Contract with Solvay Pharmaceuticals
- Positive Phase 2 Results for the VEGF Trap-Eye
- Novartis and Massachusetts Institute of Technology (MIT) in new partnership
- Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation
- Takeda to Sponsor Berlin Marathon 2007